Baird analyst Joe Vruwink initiates coverage on TransMedics Gr (NASDAQ:TMDX) with a Outperform rating and announces Price Target of $200.
Baird Initiates Coverage On TransMedics Gr With Outperform Rating, Announces Price Target of $200
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.